EDGAR Filing Documents for 0001143313-11-000004

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:

SEC Accession No. 0001143313-11-000004

Filing Date

2011-01-26

Accepted

2011-01-26 15:29:36

Documents

Confirming Copy

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	25-NSE
1		primary_doc.xml	25-NSE	1145
2		rgnform2501262011.htm	EX-99.25	16822
	Complete submission text file	0001143313-11-000004.txt		20201

Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814

Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992

REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-15070
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 BROAD STREET, 17TH FLOOR NEW YORK NY 10005

Business Address 20 BROAD STREET, 17TH FLOOR NEW YORK NY 10005 212-656-5024

NYSE Amex (Filed by) CIK: 0001143313 (see all company filings)

IRS No.: 522127241
Type: 25-NSE